Vericel Q4 Earnings Call Highlights
Vericel (NASDAQ:VCEL) executives told investors the company closed 2025 with “outstanding” fourth-quarter performance, posting record revenue and profitability while advancing several growth initiatives tied to its MACI cartilage repair franchise and its burn care products. Record fourth-quarter revenue and profitability President and CEO Nick Colangelo said Vericel delivered record fourth-quarter total revenue that increased 23% [...]